This compound is primarily used in the pharmaceutical industry as a key intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring trifluoromethyl groups, makes it valuable in the development of drugs targeting central nervous system disorders, including anxiety and depression. The chiral nature of the molecule allows for the production of enantiomerically pure compounds, which is crucial for enhancing drug efficacy and reducing side effects. Additionally, it is employed in research and development for creating novel therapeutic agents, particularly in the field of neuropharmacology. Its unique properties also make it suitable for use in organic synthesis, where it serves as a building block for complex molecules.